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ORIGINAL ARTICLE
hMYH and hMTH1 cooperate for survival in mismatch repair
defective T-cell acute lymphoblastic leukemia
S Eshtad, Z Mavajian, SG Rudd, T Visnes, J Boström, M Altun and T Helleday
hMTH1 is an 8-oxodGTPase that prevents mis-incorporation of free oxidized nucleotides into genomic DNA. Base excision
and mismatch repair pathways also restrict the accumulation of oxidized lesions in DNA by removing the mis-inserted
8-oxo-7,8-dihydro-2'-deoxyguanosines (8-oxodGs). In this study, we aimed to investigate the interplay between hMYH DNA
glycosylase and hMTH1 for cancer cell survival by using mismatch repair defective T-cell acute lymphoblastic leukemia (T-ALL) cells.
To this end, MYH and MTH1 were silenced individually or simultaneously using small hairpin RNAs. Increased sub-G1 population and
apoptotic cells were observed upon concurrent depletion of both enzymes. Elevated cell death was consistent with cleaved caspase
3 accumulation in double knockdown cells. Importantly, overexpression of the nuclear isoform of hMYH could remove the G1 arrest
and partially rescue the toxicity observed in hMTH1-depleted cells. In addition, expression profiles of human DNA glycosylases were
generated using quantitative reverse transcriptasePCR in MTH1 and/or MYH knockdown cells. NEIL1 DNA glycosylase, involved in
repair of oxidized nucleosides, was found to be significantly downregulated as a cellular response to MTH1MYH co-suppression.
Overall, the results suggest that hMYH and hMTH1 functionally cooperate for effective repair and survival in mismatch repair
defective T-ALL Jurkat A3 cells.
Oncogenesis (2016) 5, e275; doi:10.1038/oncsis.2016.72; published online 5 December 2016
INTRODUCTION
Genomic DNA is under constant attack by reactive oxygen species
that occur naturally as by-products of aerobic metabolism.
Increased production of reactive oxygen species is widely
considered to be a consequence of malignant transformation in
many cancer types,1,2 and thus efficient repair of oxidized DNA
lesions is considered critical for cancer cell survival.3,4 Perhaps the
most abundant and extensively studied oxidized DNA lesion is
8-oxo-7,8-dihydro-2'-deoxyguanosine (8-oxodG).5
Three major DNA repair pathways are thought to be responsible
for preventing the accumulation of oxidized lesions in genomic
DNA (Supplementary Figure S1). Oxidation can occur in the
deoxyribonucleotide (dNTP) pool where the MutT homolog-1
(hMTH1) enzyme, encoded by the NUDT1/MTH1 gene, hydrolyses
8-oxodGTP and other oxidized dNTPs into the monophosphate
form.6 hMTH1 thus sanitizes the dNTP pool to avoid mis-
incorporation of 8-oxodGTP into DNA during replication.7,8 When
8-oxodG is already present in the DNA strand, replicative
polymerases could incorporate either deoxycytidine triphosphate
(dCTP) or deoxyadenosine triphosphate (dATP) opposite the lesion
in the next round of replication, where 8-oxodG is in anti or syn
conformation, respectively.9,10 The 8-oxodG:C pairs are thought to
be mainly detected and further processed by 8-oxoguanine DNA
glycosylase (OGG1) that performs the first step of base excision
repair (BER), removing the oxidized guanine paired with
cytosine.11 The 8-oxodG:A mispairs are recognized by another
DNA glycosylase called MutY homolog (hMYH, encoded by MYH
gene) that excises the mis-incorporated dA in the nascent DNA
strand. This provides the BER polymerases with an opportunity to
correctly insert dCTP opposite 8-oxodG and thus create a
substrate for OGG1.12,13 On the other hand, the activity of hMYH
on 8-oxodG:A where dA is in the template strand can potentially
lead to T:A 44G:C mutations, and in this case, it has been
hypothesized that the mismatch repair (MMR) pathway could
contribute to the removal of the 8-oxodG in the nascent
strand.1416
In order to investigate the interplay between hMTH1- and
hMYH-dependent BER, we utilized MMR defective T-cell acute
lymphoblastic leukemia (T-ALL) cells.17 Malfunctioned MMR and
the consequent microsatellite instability are highly frequent
in T-ALL and thus simplify our study model.1821 In addition,
RNA-sequencing analysis of over 900 human cancer cell lines
revealed that T-ALL cells have the highest expression for both
MTH1 and MYH, making them an ideal model for this study22
(Supplementary Figure S2). To achieve simultaneous silencing of
both genes, small hairpin RNA (shRNA) sequences from The
RNA Consortium (TRC) library were cloned into doxycycline
(Dox)-inducible vectors containing different fluorescent reports
(green fluorescent protein (GFP) or RFP670), followed by lentiviral
transduction of Jurkat A3 cells. Next, the top 15% double positive
cells were sorted using fluorescence-activated cell sorting (FACS).
The cells were cultured in the presence of Dox and samples were
harvested after 96 h for downstream assays.
Here, we observed higher cell death following MTH1 and MYH
double knockdown (KD) compared with individual KD. Expression
profiling of human DNA glycosylases revealed their responses to
the lack of hMTH1 and hMYH enzymes. Taken together, our results
indicated that hMTH1 and hMYH functionally cooperate for cell
survival in T-ALL Jurkat A3 cells.
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RESULTS
Efficient individual and simultaneous KD of MYH and MTH1
To study the potential functional interactions between hMYH and
hMTH1, two different shRNA sequences for each gene were
cloned into separate inducible vectors containing either GFP or
RFP670 fluorescent reporters. T-ALL Jurkat A3 cells were then
co-transduced with lentiviral particles to establish stable cell lines
concurrently expressing two different hairpins. Puromycin
selected cells were subsequently sorted for the highest expression
of both reporters (Figure 1a) and KD efficiency of each hairpin was
analyzed using quantitative reverse transcriptasePCR (qRTPCR)
(Figures 1b and c). Under these conditions, both MYH shRNAs
were able to significantly suppress the expression of their target
gene when co-expressed with a not-targeting hairpin. Similarly,
MTH1 was also significantly down regulated by its respective
shRNAs. Furthermore, simultaneous silencing of both genes was
successfully achieved when MTH1 and MYH hairpins were used in
combination. Interestingly, following 96 h of KD, MTH1-shRNA1
showed a suppressive effect on MYH expression (Figure 1b). In
contrast, MTH1-shRNA2 resulted in a slight increase in MYH mRNA
level (Figure 1c). We next validated hairpin activities at protein
level using western blot analysis (Figures 1d and e), and obtained
results comparable to the gene expression data. At both
time-points, hMYH protein level was considerably reduced in cells
expressing MYH-shRNAs separately or in combination with
MTH1-shRNAs. Similar to qRTPCR results, the hMTH1 protein KD
was more efficient compared with hMYH, regardless of whether its
corresponding shRNAs were used individually or co-expressed
with MYH hairpins. Interestingly, in the cells containing single
MTH1-shRNA2, a dramatically increased hMYH level was observed
(Figure 1e). Possibly because of this effect, hMYH depletion level
after 96 h was not statistically significant when the MYH hairpin
was combined with MTH1-shRNA2. Thus, hMYH protein KD 96 h
post treatment was more efficient when MYH-shRNA2 was used
separately rather than in combination with MTH1-shRNA2.
Collectively, these results demonstrate highly efficient individual
and combinatorial KD of the both genes.
hMYH and hMTH1 functionally collaborate to sustain cell survival
in a T-ALL cell line
We first investigated the effect of MTH1 and MYH double KD on
survival of Jurkat A3 cells. On one hand, high DNA 8-oxodG caused
by MTH1 KD could lead to more putative DNA strand breaks
mediated by hMYH, causing cell death. Therefore, based on this
hypothesis, hMYH depletion would rescue the toxicity induced by
the lack of hMTH1.23 On the other hand, hMYH hyperactivation
could be a compensatory mechanism in the context of hMTH1
inhibition. Accordingly, a synergistic lethality would be expected
as a consequence of combinatorial suppression of both enzymes.
To test these hypotheses, we measured the percentage of sub-G1
cells upon Dox treatment in the cells with shRNA-set1 and
shRNA-set2 at 96 h time-point. We observed concurrent KD of
both proteins induced more cell death compared with individual
depletions in both hairpin sets (Figure 2). These observations
support the hypothesis that hMYH function is required for cell
survival when hMTH1 activity is suppressed.
To further understand how simultaneous KD of both genes
influences survival in T-ALL cells, we studied induction of
apoptosis using specific markers such as Annexin V and cleaved
caspase 3 (Figure 3). We observed that the percentage of Annexin
V-positive cells was higher in combined KD shRNA set1 compared
with single KD of either genes (Figure 3a). Intriguingly, there was
no significant difference in apoptosis level between the cells with
combined KD and the ones expressing MTH1-shRNA2 (Figure 3b),
and this could be owing to the increased hMYH level following
MTH1-shRNA2 KD. As total cell death is also increased in the
MTH1/MYH-shRNA2 KD, a more likely explanation is that the
timing of apoptosis is such that the number of actively apoptotic
cells at 96 h is lower. In addition, measurement of cleaved caspase
3 confirmed the results of Annexin V analysis (Figures 3c and d).
Taken together, these results support the hypothesis that hMYH is
required for cell survival in the absence of hMTH1.
hMYH overexpression can rescue G1 arrest and cell death in MTH1
KD cells
To further test our hypothesis that hMYH is required for cell
survival in the absence of hMTH1, we speculated that hMYH
overexpression could rescue the phenotypes observed following
hMTH1 depletion. To test this, we transduced the individual
MTH1-shRNA cell lines with a Dox-inducible construct over-
expressing a nuclear isoform of hMYH (γ3) and performed cell
cycle analysis following 96 h of treatment with Dox (Figure 4).
We observed that hMYH overexpression could remove the G1
block introduced by hMTH1 depletion. Furthermore, increased
γ3-hMYH activity was shown to partially rescue the cell death
mediated by MTH1 suppression. These data further support that
hMYH levels dictate the cell survival to hMTH1 depletion, and
suggest a protective role for hMYH.
NEIL1 expression was suppressed upon combined depletion of
hMYH and hMTH1
MTH1 and MYH double KD, in a MMR-defective background, would
presumably lead to high levels of oxidized DNA lesions. Here we
wanted to investigate potential compensatory transcriptional
response of the DNA glycosylase family to reduced levels of
hMTH1 or hMYH protein levels. We speculated that MTH1 and
MYH double KD would lead to increased genomic oxidized lesions,
and this may lead to compensational changes in expression of BER
enzymes. To investigate this we performed qRTPCR following
single or double KD, and measured the expression level of all
known human DNA glycosylases. MTH1 and MYH double KD led to
decreased NEIL1 expression level to ∼ 30% in both hairpin sets
(Figures 5a and b). No considerable changes were observed in the
expression of other DNA glycosylases (Figure 5a). These results
implicate NEIL1 in the cellular response to excess genomic
oxidized lesions, caused here by MTH1 and MYH double KD.
DISCUSSION
It has been suggested that processing of mis-incorporated
8-oxodG opposite dA is mainly mediated by post-replicative
MMR in mammalian cells.13 In addition, hMYH activity has been
shown to be required for removal of dA from the nascent strand
when mispaired with 8-oxodG,14 and there is also cumulative
evidence suggesting hMYH has physical interactions as well as
functional cooperation with MMR.14,24 Using data base mining,
we observed MYH and MTH1 expression levels are particularly high
in T-ALL (Supplementary Figure S2). It has been reported that
primary cells obtained from adult T-ALL patients are MMR
inactive.21,25,26 Hence, this may reflect that hMYH and hMTH1
proteins are particularly important in the absence of MMR.
Moreover, the majority of established T-ALL cell lines appeared
to contain defects in MMR.20,27 Therefore, we used MMR-defective
T-ALL Jurkat A3 cells to study the interplay between hMYH
and hMTH1. Supporting the involvement of MMR, hMTH1
overexpression has been reported to significantly decrease
spontaneous mutation rate in MMR-defective cells, indicating
an oxidized dNTP pool critically contributes to their genomic
instability.28
Using two separate inducible vectors, we succeeded in
knocking down MTH1 and MYH separately or simultaneously
(Figures 1b and c). MTH1 suppression via MTH1-shRNA2 caused
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Figure 1. Simultaneous suppression of MTH1 and MYH was efficiently achieved using a two-vector system. (a) Steps of cell line establishment
are illustrated here. Top 15% of cells expressing GFP and RFP670 were sorted to improve the knockdown efficiency. Expression levels of MYH
and MTH1 were analyzed after 96 h of treatment with Dox in shRNA set1 (b) and shRNA set2 (c) using qRT–PCR analysis. Data were normalized
to NT-shRNA expressing cells and presented as mean± s.e.m. from three independent experiments in triplicate. To investigate the knockdown
efficiency at protein level, western blot analysis was performed after 96 h of Dox treatment of cells with shRNA set1 (d) and shRNA set2 (e).
Data were double normalized with GAPDH and NT-shRNA control samples and expressed as percentage. The graphs represent mean± s.e.m.
from three independent experiments. P-values were calculated using one-way analysis of variance (ANOVA). *Po0.05, **Po0.01, ***Po0.001,
****P⩽ 0.0001, NS, not significant.
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MYH upregulation, whereas the other hairpin, MTH1-shRNA1,
showed a downregulation at 96 h that was also reported earlier.8
The upregulation of hMYH protein level in MTH1-shRNA2-
expressing cells was confirmed using western blotting
(Figure 1e). The varying response may be a reflection of the
intricate relationship likely existing between the hMTH1 and
hMYH proteins.
We found that simultaneous MTH1 and MYH suppression
increased the sub-G1 population significantly using both shRNA
sets, showing that the two proteins collaborate for survival in
T-ALL Jurkat A3 line. Interestingly, ongoing apoptosis, measured
by Annexin V and cleaved caspase 3, at the 96 h time-point was
different between the two treatments (Figure 3), likely a reflection
of the different degrees of knockdown and timing of cell death
between the conditions used. However, the specific role of hMYH
in promoting survival was established by overexpression of the
γ3-hMYH into MTH1-shRNA-containing cells that decreased overall
cell death (Figure 4). These results support the hypothesis that
hMYH and hMTH1 cooperate to avoid the accumulation of
genomic DNA damage and consequent cell death.
To understand how MYH and/ or MTH1 suppression can
modulate the DNA repair pathways we analyzed the expression
levels of human DNA glycosylases after 96 h of Dox treatment.
Interestingly, we found that NEIL1 expression was significantly
reduced when both enzymes were depleted (Figure 5). Hydantoin
lesions arising from oxidation of 8-oxodG are known substrates for
NEIL1.29 In addition, NEIL1 exhibited pre-replicative repair of
oxidized lesions preventing the progression of the nascent strands
containing NEIL1 substrates. Accordingly, hyperactivation of NEIL1
has been reported to cause replication fork stalling.30 Based on
this, we speculate that cells, with potential increased 8-oxodG
levels caused by hMTH1 or hMYH loss, may suppress NEIL1
expression to avoid incised hydantoin lesions (converted to DNA
single-strand breaks) to cause replication fork collapse and DNA
double-strand breaks. A speculative hypothesis, still to be tested,
could be that the hydantoin lesion is less toxic and better for
survival than conversion to potentially toxic BER intermediates.
In conclusion, this study provides evidence for the functional
collaboration between hMYH and hMTH1 to maintain survival in
cancer cells with MMR defective backgrounds, in particular T-ALL
Jurkat A3 cells.
MATERIALS AND METHODS
Molecular cloning and DNA constructs
The shRNA plasmids were generated by cloning oligonucleotide from TRC
library (Supplementary Table S1) into an inducible shRNA vector system,
created through modifying pRSITEP-U6Tet-(sh)-EF1-TetRep-2A-Puro
plasmid (Cellecta, Inc., Mountain View, CA, USA) by replacing the
TetRep-2A-Puromycin site with either TetRep-P2A-Puro-P2A-RFP670 or
TetRep-P2A-Puro-P2A-GFP. The vector contains a 1.2 kb stuffer sequence
that was doubledigested by FastDigest BshTI and EcoRI (FD1464 and
FD0274; Thermo Fisher, Waltham, MA, USA) for 1 h. The 8 kb BshTI/EcoRI
band was extracted from 1% agarose gel using Wizard SV Gel and PCR
Clean-Up System (A9280; Promega, Madison, WI, USA). Separate forward
and reverse oligos (custom DNA oligo service; Sigma) were annealed in the
annealing buffer (10 mM Tris-HCl, pH 7.5, 0.1 M NaCl and 1 mM EDTA) using
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a thermal cycler (C1000; Bio-Rad), incubating for 5 min at 95 °C and then
cooling gradually to 20 °C, and 1 μl of annealed oligo pairs was ligated into
50100 ng of the digested vector using T4 DNA ligase (EL0014; Thermo
Fisher) and T4 Polynucleotide Kinase (EK0031; Thermo Fisher), incubated
overnight at 37 °C. Transformation was conducted using One Shot Stbl3
Chemically Competent Cells (C737303; Thermo Fisher) according to the
manufacturers protocol. Next, at least three colonies were picked for
colony PCR using DreamTaq Green PCR Master Mix (K1081; Thermo Fisher).
The primers used for this reaction were U6-tet-F: 5-GGA CTA TCA
TAT GCT TAC CGT AAC-3 and U6-tet-R: 5-TGG ATG AAT ACT
GCC ATT TGT CTC-3. Colonies lacking the stuffer were sent for sequencing
(à la Carte Sequencing Service; Eurofins Genomics, Ebersberg, Germany).
After sequencing validation of the constructs, a GFP reporter from pRSITEP-
V2-GFP vector replaced the RFP670 cassette using double-digest reactions
with FastDigest SalI and FastDigest XbaI (FD0644 and FD0684; Thermo
Fisher).
The γ3-hMYH overexpression plasmid was generated by PCR amplifica-
tion of MYH cDNA (GenBank accession number AF527839.1) using the
following primers: 5-TAT AGT CGA CAT GAG GAA GCC ACG-3 and
5-TAT AGC GGC CGC TCA CTG GGC TGC ACT G-3. Double digestion
reactions were carried out with FastDigest SalI and NotI (FD0644 and
FD0593; Thermo Fisher) for 1 h. The PCR product was then ligated into
pENTR1A no ccDB (17398; Addgene, Cambridge, MA, USA) entry vector
using T4 DNA ligase (EL0014; Thermo Fisher). The entry vectors carrying γ3-
hMYH insert were verified by sequencing (Eurofins Genomics). Next, the
insert from entry vector was transferred to pINDUCER20 (44012; Addgene)
destination vector using Gateway LR Clonase II (11791100; Thermo Fisher).
Finally, the constructs were validated by colony PCR using DreamTaq
Green PCR Master Mix (K1081; Thermo Fisher).
Establishment of stable cell lines
Production of lentiviruses was performed following the protocol by
Genetic Perturbation Platform, Broad Institute (http://www.broad.mit.edu/
genome_bio/trc/rnai.html). Briefly, HEK-293T packaging cells were
transfected by a shRNA vector together with packaging plasmids (12 260
and 12259; Addgene) in 96-well plates. Virions were collected at 36 and
60 h post transfection and directly 25 μl of supernatant was used to
transduce T-cell ALL cells in 96-well plates. Next day, cells were transferred
into 24-well plates containing media with 0.51 μg/ml puromycin
(A1113803; Thermo Fisher), selected for 6 days. Afterwards, top 15% of
GFPRFP670-positive cells were sorted in SciLifeLab FACS facility using BD
Influx Cell Sorter (BD Biosciences, San Jose, CA, USA). For the cells
transduced with only one shRNA plasmid, top 10% of RFP670-positive cells
were sorted. Cells transduced with pINDUCER20 plasmids were selected for
12 days using 750 μg/ml G418 (G8168; Sigma, Darmstadt, Germany).
Cell culture and treatments
T-cell ALL Jurkat A3 cell line was obtained from ATCC (Manassas, VA, USA)
and grown in RPMI media (61870044; Thermo Fisher) with 10% fetal
bovine serum (16140071; Thermo Fisher). Cells were cultured in T-75 flasks,
treated with 250 ng/ml doxycycline hyclate (D9891; Sigma) and samples
were collected at 96 h post-doxycycline treatment for downstream
applications such as qRTPCR, western blotting, flow cytometry and so on.
qRTPCR analysis
Total RNA was extracted from cells using Direct-zol RNA MiniPrep Kit
(R2053; Zymo Research, Irvine, CA, USA). RNA (500 ng) was used to
synthesize cDNA using iScript cDNA Synthesis Kit (1708891; Bio-Rad,
Hercules, CA, USA). qRTPCR reactions were carried out using primers
listed in Supplementary Table S2 and iTaq Universal SYBR Green Supermix
(1725124; Bio-Rad) on a CFX96 Touch Real-Time PCR Detection System
(Bio-Rad). Analysis of data was performed using CFX Manager Software
(Bio-Rad). The qRTPCR experiments were carried out independently at
least three times in technical triplicate.
Western blotting analysis
Cells were washed once with cold phosphate-buffered saline (PBS) and
then resuspended in a lysis buffer (50 mM Tris-Cl, pH 7.5, 150 mM NaCl,
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Figure 5. NEIL1 was downregulated upon concurrent suppression of MTH1 and MYH. (a) Expression of DNA glycosylases were analyzed after
96 h of Dox treatment using qRT–PCR and the results are shown in a heat-map diagram. (b) Detailed NEIL1 expression levels are represented in
a bar chart. Data are presented as mean± s.e.m. from three independent experiments in triplicate. P-values were obtained using one-way
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Protease Inhibitor Cocktail (04693116001; Roche, Basel, Switzerland), Halt
Phosphatase Inhibitor Cocktail (78420; Thermo Fisher)). Cell lysis was
prepared by three repeated thawfreeze cycles at 37 °C and − 80 °C. Pierce
BCA Protein Assay Kit (34095; Thermo Fisher) was used to determine
protein concentration in the samples. At least 12 μg of total lysate was
loaded on the SDSpolyacrylamide gel electrophoresis. Membranes were
blocked with PBS plus 0.05% (v/v) Tween-20 containing either 3% bovine
serum albumin or 5% skimmed milk powder for 1 h at room temperature,
followed by overnight incubation with primary antibodies at 4 °C.
Incubation with secondary antibodies was carried out at room temperature
for 45 min. For horseradish peroxidase (HRP)-conjugated secondary
antibodies, SuperSignal West Femto Maximum Sensitivity Substrate
(34095; Thermo Fisher) was used. Images were acquired using Odyssey
Fc imager (LI-COR, Biosciences, Lincoln, NE, USA) and analyzed by Image
Studio Lite (LI-COR). Where indicated, membranes were stripped by
Restore Western Blot Stripping Buffer (21059; Thermo Fisher). Primary
antibodies used were: GAPDH (sc-25778; Santa Cruz, Dallas, TX, USA),
hMTH1 (NB100-109; Novus Biologicals, Littleton, CO, USA), hMYH
(H00004595-M01; Abnova, Taipei, Taiwan) and Active Caspase-3
(ab32042; Abcam, Cambridge, UK). The following were used as secondary
antibodies: Anti-Rabbit IgG-HRP conjugate (711-035-152; Jackson Immuno
Research, West Grove, PA, USA), Anti-Mouse IgG-HRP conjugate (715-035-
150; Jackson Immuno Research), Anti-Rabbit IgG-IRDye 680RD (925-68073;
LI-COR) and Anti-Mouse IgG-IRDye 800CW (925-32212; LI-COR). The
western blotting was performed independently at least three times.
Flow cytometry
For DNA content measurement, cells were washed with PBS and fixated in
cold 70% ethanol overnight. After resuspension of cell pellets in PBS with
1% bovine serum albumin, samples were incubated in DNA staining
solution (10 μg/ml DAPI (D9542; Sigma), 0.1 mg/ml RNase A (EN0531;
Thermo Fisher) and 1% bovine serum albumin in PBS) for 20 min at room
temperature, followed by flow cytometry analysis on a Navios Flow
Cytometer (Beckman Coulter, Brea, CA, USA). Data were analyzed using
Kaluza Flow Analysis Software (Beckman Coulter).
For apoptosis detection, cells were washed with PBS and resuspended in
Annexin V Binding Buffer (556454; BD Biosciences) containing 1:100
diluted Annexin V, Alexa Fluor 555 conjugate (A35108; Thermo Fisher) and
10 μg/ml DAPI (D9542; Sigma), incubated for 20 min at room temperature
in the dark before flow cytometry analysis. The flow cytometry
experiments were performed independently at least three times in
technical duplicate.
Statistical analysis
Multiple comparison between groups was performed by analysis of
variance test using Prism 6 (GraphPad Software, La Jolla, CA, USA). Data are
presented as mean± s.e.m. and differences with values of Po0.05 were
considered to be statistically significant.
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